SCHEMBL1317364

SCHEMBL1317364

CCOc1cc(-c2cc(N3CCOC[C@H]3CC)nc(NC)n2)cc2[nH]nc(N)c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 13/20 0.58
▸ AURKA O14965 6/20 0.58
▸ AURKB Q96GD4 10/20 0.48
▸ ROCK1 Q13464 6/20 0.48
▸ ATR Q13535 1/20 0.38
▸ PIK3CG P48736 1/20 0.37
▸ PDK1 Q15118 1/20 0.37
▸ PIK3CA P42336 3/20 0.36
▸ MTOR P42345 3/20 0.36
▸ LRRK2 Q5S007 1/20 0.35
▸ CDC7 O00311 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ PRKACA P17612 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ HIPK2 Q9H2X6 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ IRAK4 Q9NWZ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1318982 0.92 PDPK1 (0.59) PDPK1AURKAAURKBROCK1ATR
SCHEMBL1318863 0.92 PDPK1 (0.54) PDPK1AURKAAURKBROCK1ATR
SCHEMBL1319765 0.90 PDPK1 (0.71) PDPK1AURKAAURKBROCK1ATR
SCHEMBL1317214 0.90 PDPK1 (0.55) PDPK1AURKAAURKBROCK1ATR
SCHEMBL1319651 0.88 PDPK1 (0.47) PDPK1AURKAAURKBROCK1PIK3CG
SCHEMBL1321060 0.88 PDPK1 (0.61) PDPK1AURKAAURKBROCK1ATR
SCHEMBL1320904 0.87 PDPK1 (0.59) PDPK1AURKAAURKBROCK1ATR
SCHEMBL1317815 0.87 PDPK1 (0.60) PDPK1AURKAAURKBROCK1ATR
SCHEMBL1317057 0.85 PDPK1 (0.58) PDPK1AURKAAURKBROCK1ATR
SCHEMBL1319884 0.84 PDPK1 (0.80) PDPK1AURKAAURKBROCK1PIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2362775-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-08-05 — — EP claimed
US-8697685-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2014-04-15 — — US claimed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 — — US claimed
EP-2362775-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-08-05 — — EP disclosed
EP-2362775-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-08-05 — — EP disclosed
US-8697685-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2014-04-15 — — US disclosed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 — — US disclosed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 — — US disclosed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 — — US disclosed
WO-2010059658-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-05-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275611-A1 CHEMICAL COMPOUNDS PDK1, PDK2, PDK3 PDPK1 12/4885AURKA 298/4885AURKB 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback